Zobrazeno 1 - 10
of 72
pro vyhledávání: '"Martha L. Louzada"'
Autor:
Arleigh McCurdy, Donna Reece, Martha L. Louzada, Darrell White, Stephen Parkin, Michael P. Chu, Rami Kotb, Hira Mian, Ibraheem Othman, Jiandong Su, Aniba Khan, Engin Gul, Suzanne Trudel
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-9 (2024)
Abstract Given the early use of triplet and quadruplet regimens, most patients with multiple myeloma (MM) will be exposed and/or refractory to PIs, IMiDs, and anti-CD38 mAbs after first- or second-line treatment. Effective treatment for this group of
Externí odkaz:
https://doaj.org/article/c10a5855b43241bab5df62d88db58644
Autor:
Julie Côté, Rami Kotb, Debra J. Bergstrom, Richard LeBlanc, Hira S. Mian, Ibraheem Othman, Martha L. Louzada
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 23:340-354
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::452f67426ed9e2aefd9d0bc9a7b991e7
https://doi.org/10.1016/j.clml.2023.01.016
https://doi.org/10.1016/j.clml.2023.01.016
Autor:
Julie Cote, Richard Leblanc, Michael P. Chu, Arleigh McCurdy, Esther Masih-Khan, Moustafa Kardjadj, Victor H Jimenez-Zepeda, Kevin Song, Martha L Louzada, Hira S Mian, Darrell White, Michael Sebag, Anthony Reiman, Julie Stakiw, Rami Kotb, Debra Bergstrom, Muhammad Aslam, Rayan Kaedbey, Christopher P. Venner, Engin Gul, Donna E. Reece
Publikováno v:
Blood. 140:289-291
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08073ad1b4b0ddf429bfb6bddf28d77e
https://doi.org/10.1182/blood-2022-158219
https://doi.org/10.1182/blood-2022-158219
Autor:
Alissa Visram, Alfredo De La Torre, Darrell White, Moustafa Kardjadj, Esther Masih-Khan, Michael P. Chu, Victor H Jimenez-Zepeda, Arleigh McCurdy, Richard Leblanc, Kevin Song, Hira S Mian, Martha L Louzada, Michael Sebag, Debra Bergstrom, Julie Stakiw, Anthony Reiman, Rami Kotb, Muhammad Aslam, Christopher P. Venner, Rayan Kaedbey, Engin Gul, Donna E. Reece
Publikováno v:
Blood. 140:4287-4289
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::195b33910f58a30e1ea434175e3513d5
https://doi.org/10.1182/blood-2022-168843
https://doi.org/10.1182/blood-2022-168843
Autor:
Richard Leblanc, Christopher P. Venner, Esther Masih-Khan, Moustafa Kardjadj, Michael P. Chu, Victor H Jimenez-Zepeda, Arleigh McCurdy, Kevin Song, Michael Sebag, Martha L Louzada, Hira S Mian, Darrell J White, Julie Stakiw, Rami Kotb, Anthony Reiman, Muhammad Aslam, Rayan Kaedbey, Engin Gul, Donna E. Reece
Publikováno v:
Blood. 140:7192-7194
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::43fe7586f452443738dbaad59545ae1d
https://doi.org/10.1182/blood-2022-158679
https://doi.org/10.1182/blood-2022-158679
Autor:
Martha L Louzada, Heather J. Sutherland, Debra J. Bergstrom, Richard Leblanc, Rami Kotb, Julie Cote
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 22:e41-e56
Multiple myeloma (MM) is a hematological cancer associated with significant symptomatic burden. Bone disease, renal insufficiency, cytopenias, infection, and peripheral neuropathy, among other disease manifestations and complications, impair patients
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e0d64115cf20f4632251910f2916c6c
https://doi.org/10.1016/j.clml.2021.07.028
https://doi.org/10.1016/j.clml.2021.07.028
Autor:
James Gordon Payne, Martha L Louzada, Michael J. Kovacs, Dou-Anne Siew, Eri Kawata, Alejandro Lazo-Langner
Publikováno v:
Thrombosis Research. 202:90-95
Background Clinical manifestations and optimal management strategies in patients with splanchnic vein thrombosis (SVT) are not well characterized. Methods We conducted a retrospective cohort study including all newly diagnosed SVT evaluated between J
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9d5b295cb0d7211d765fbf63fdde09ac
https://doi.org/10.1016/j.thromres.2021.03.018
https://doi.org/10.1016/j.thromres.2021.03.018
Autor:
Donna E. Reece, Eshetu G. Atenafu, Michael Sebag, Christopher P. Venner, Rami Kotb, Victor H Jimenez-Zepeda, Hannah Cherniawsky, Julie Stakiw, Engin Gul, Richard Leblanc, Esther Masih-Khan, Anthony Reiman, Arleigh McCurdy, Muhammad Aslam, Darrell White, Martha L Louzada, Vishal Kukreti, Kevin W. Song
Publikováno v:
European Journal of Haematology. 106:673-681
Objectives To understand the impact of therapy sequencing on progression-free (PFS) and overall survival (OS) for the treatment of multiple myeloma (MM). The use of daily, low-dose, lenalidomide maintenance (LM) has raised concern for fostering resis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45bfe20bc3276d05e0263887450bb94c
https://doi.org/10.1111/ejh.13596
https://doi.org/10.1111/ejh.13596
Autor:
Kevin W. Song, Tony Reiman, Richard Leblanc, Victor H Jimenez-Zepeda, Martha L Louzada, Esther Masih-Khan, Michael Sebag, Julie Stakiw, Christopher P. Venner, Rami Kotb, Arleigh McCurdy, Eshetu G. Atenafu, Engin Gul, Donna E. Reece
Publikováno v:
British Journal of Haematology. 193:532-541
Bortezomib-containing regimens (BCRs) represented standard, first-line therapy for transplant-ineligible multiple myeloma (TIMM) in Canada until the introduction of lenalidomide and low-dose dexamethasone (Ld). However, little comparative data exist
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d46737dfb948dd275926fad1fe26fc37
https://doi.org/10.1111/bjh.17350
https://doi.org/10.1111/bjh.17350
Autor:
Hira S Mian, Martha L Louzada, Arleigh McCurdy, Ruthanne Cameron, Gregory R Pond, Tanya Wildes, Darryl Leong
Publikováno v:
Blood. 140:2395-2396
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93e3067369fa17a22802f52a6e35194c
https://doi.org/10.1182/blood-2022-158301
https://doi.org/10.1182/blood-2022-158301